Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Cancer

Date Submitted: Mar 9, 2026
Open Peer Review Period: Mar 17, 2026 - May 12, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

The Oncology Care Model and Health Care Competition: A Retrospective Cohort Study

  • Nicole Murray; 
  • Joshua J. Horns; 
  • Jonathan Chipman; 
  • Hailie Gill; 
  • Jiaming Li; 
  • Richard Nelson; 
  • Brock O’Neil

ABSTRACT

Background:

The Oncology Care Model aims to improve the value of oncology care. However, concerns exist that the Oncology Care Model participation could accelerate consolidation among smaller oncology practices, threatening market competition.

Objective:

To evaluate whether participation in the Oncology Care Model is associated with changes in oncology market competition across U.S. regions, using the Herfindahl–Hirschman Index to assess competition within Dartmouth Health Referral Regions.

Methods:

A cross-sectional analysis was conducted using Medicare claims data to identify oncology practices participating in the OCM. Market competition was assessed using the Hirschman-Herfindahl Index (HHI) across Dartmouth Health Referral Regions (HRRs) from 2015 to 2019. Demographic and socioeconomic factors were incorporated using American Community Survey data.

Results:

Market competition, as measured by HHI, remained stable from 2015 to 2019 across regions with varying levels of OCM adoption, indicating no significant impact on competition. Patient demographics and area-level socioeconomic factors minimally influenced HHI trends.

Conclusions:

The findings suggest that OCM adoption does not drive significant practice consolidation. This supports the OCM as a model that enables both smaller and larger practices to deliver high-value, patient-centered oncology care without undermining market competition. Clinical Trial: Not applicable


 Citation

Please cite as:

Murray N, Horns JJ, Chipman J, Gill H, Li J, Nelson R, O’Neil B

The Oncology Care Model and Health Care Competition: A Retrospective Cohort Study

JMIR Preprints. 09/03/2026:94939

DOI: 10.2196/preprints.94939

URL: https://preprints.jmir.org/preprint/94939

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.